Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer. (2018)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdx483
PubMed Identifier: 29045530
Publication URI: http://europepmc.org/abstract/MED/29045530
Type: Journal Article/Review
Volume: 29
Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology
Issue: 1
ISSN: 0923-7534